<?xml version="1.0" encoding="UTF-8"?>
<p>Subjects derived from multiple North-American and European PD research cohorts (table e-1, 
 <ext-link ext-link-type="uri" xlink:href="http://links.lww.com/NXG/A373" specific-use="external-ds" xmlns:xlink="http://www.w3.org/1999/xlink">links.lww.com/NXG/A373</ext-link>): Baylor College of Medicine (BCM), University of Maryland, Baltimore PD Genetics Study, Parkinson's Progression Markers Initiative, Parkinson's Disease Biomarkers Program, Profiling Parkinson's disease study (Netherlands), Tracking Parkinson's study (United Kingdom), and the Oslo Parkinson's Disease study (Norway). All participants provided written informed consent for genomic studies, including permission for sharing of deidentified data between institutions, before enrollment in the respective studies. We obtained all clinical and genetic information with approval of the respective local institutional review boards.
</p>
